Search research articles
Contact Us
Filters
Showing results (71-80 of 107) with videos related to
Page
of 11
Sort By:
Annals of the Rheumatic Diseases
|
February 2, 2012
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
Christian Beyer, Nicole Reich, Sonia C Schindler, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 27, 2014
The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis
Jérôme Avouac, Katrin Palumbo-Zerr, Nadira Ruzehaji, et al.
Arthritis and Rheumatism
|
May 3, 2012
JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis
Clara Dees, Michal Tomcik, Katrin Palumbo-Zerr, et al.
Annals of the Rheumatic Diseases
|
March 10, 2012
Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis
Angelika Horn, Trayana Kireva, Katrin Palumbo-Zerr, et al.
Oncoimmunology
|
June 28, 2021
Immune-checkpoint blockade of CTLA-4 (CD152) in antigen-specific human T-cell responses differs profoundly between neonates, children, and adults
Aditya Arra, Maximilian Pech, Hang Fu, et al.
Annals of the Rheumatic Diseases
|
November 29, 2011
IgG4 immune response in Churg-Strauss syndrome
Augusto Vaglio, Johanna D Strehl, Bernhard Manger, et al.
Annals of the Rheumatic Diseases
|
August 24, 2012
Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis
Marlene Krämer, Clara Dees, Jingang Huang, et al.
Arthritis and Rheumatism
|
February 12, 2011
Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis
Clara Dees, Pawel Zerr, Michal Tomcik, et al.
Annals of the Rheumatic Diseases
|
January 10, 2018
Protein kinases G are essential downstream mediators of the antifibrotic effects of sGC stimulators
Alexandru-Emil Matei, Christian Beyer, Andrea-Hermina Györfi, et al.
Annals of the Rheumatic Diseases
|
August 21, 2012
Pomalidomide is effective for prevention and treatment of experimental skin fibrosis
Simon Weingärtner, Pawel Zerr, Michal Tomcik, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 107) with videos related to
Sort By:
Page
of 11
Annals of the Rheumatic Diseases
|
February 2, 2012
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
Christian Beyer, Nicole Reich, Sonia C Schindler, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 27, 2014
The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis
Jérôme Avouac, Katrin Palumbo-Zerr, Nadira Ruzehaji, et al.
Arthritis and Rheumatism
|
May 3, 2012
JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis
Clara Dees, Michal Tomcik, Katrin Palumbo-Zerr, et al.
Annals of the Rheumatic Diseases
|
March 10, 2012
Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis
Angelika Horn, Trayana Kireva, Katrin Palumbo-Zerr, et al.
Oncoimmunology
|
June 28, 2021
Immune-checkpoint blockade of CTLA-4 (CD152) in antigen-specific human T-cell responses differs profoundly between neonates, children, and adults
Aditya Arra, Maximilian Pech, Hang Fu, et al.
Annals of the Rheumatic Diseases
|
November 29, 2011
IgG4 immune response in Churg-Strauss syndrome
Augusto Vaglio, Johanna D Strehl, Bernhard Manger, et al.
Annals of the Rheumatic Diseases
|
August 24, 2012
Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis
Marlene Krämer, Clara Dees, Jingang Huang, et al.
Arthritis and Rheumatism
|
February 12, 2011
Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis
Clara Dees, Pawel Zerr, Michal Tomcik, et al.
Annals of the Rheumatic Diseases
|
January 10, 2018
Protein kinases G are essential downstream mediators of the antifibrotic effects of sGC stimulators
Alexandru-Emil Matei, Christian Beyer, Andrea-Hermina Györfi, et al.
Annals of the Rheumatic Diseases
|
August 21, 2012
Pomalidomide is effective for prevention and treatment of experimental skin fibrosis
Simon Weingärtner, Pawel Zerr, Michal Tomcik, et al.
Page
of 11